617 related articles for article (PubMed ID: 28466274)
1. Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.
Xiao J; Yang R; Biswas S; Zhu Y; Qin X; Zhang M; Zhai L; Luo Y; He X; Mao C; Deng W
Mol Neurobiol; 2018 Apr; 55(4):3152-3171. PubMed ID: 28466274
[TBL] [Abstract][Full Text] [Related]
2. Osthole augments therapeutic efficiency of neural stem cells-based therapy in experimental autoimmune encephalomyelitis.
Gao Z; Wen Q; Xia Y; Yang J; Gao P; Zhang N; Li H; Zou S
J Pharmacol Sci; 2014; 124(1):54-65. PubMed ID: 24441773
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
[TBL] [Abstract][Full Text] [Related]
4. Taking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration?
Akkermann R; Jadasz JJ; Azim K; Küry P
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854261
[TBL] [Abstract][Full Text] [Related]
5. Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
Sher F; Amor S; Gerritsen W; Baker D; Jackson SL; Boddeke E; Copray S
Cell Transplant; 2012; 21(9):1883-97. PubMed ID: 22469520
[TBL] [Abstract][Full Text] [Related]
6. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
7. LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.
Li X; Zhang Y; Yan Y; Ciric B; Ma CG; Chin J; Curtis M; Rostami A; Zhang GX
Mol Neurobiol; 2017 Aug; 54(6):4365-4378. PubMed ID: 27344330
[TBL] [Abstract][Full Text] [Related]
8. Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Mol Ther; 2017 Feb; 25(2):401-415. PubMed ID: 28153091
[TBL] [Abstract][Full Text] [Related]
9. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.
Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W
Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells.
Yang J; Yan Y; Xia Y; Kang T; Li X; Ciric B; Xu H; Rostami A; Zhang GX
Mol Ther; 2014 Feb; 22(2):440-450. PubMed ID: 24247929
[TBL] [Abstract][Full Text] [Related]
12. Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
Zhang C; Cao J; Li X; Xu H; Wang W; Wang L; Zhao X; Li W; Jiao J; Hu B; Zhou Q; Zhao T
Sci China Life Sci; 2016 Sep; 59(9):950-7. PubMed ID: 27233903
[TBL] [Abstract][Full Text] [Related]
13. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
Jadasz JJ; Aigner L; Rivera FJ; Küry P
Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
[TBL] [Abstract][Full Text] [Related]
14. Cells of the oligodendroglial lineage, myelination, and remyelination.
Miron VE; Kuhlmann T; Antel JP
Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant.
McIntyre LL; Greilach SA; Othy S; Sears-Kraxberger I; Wi B; Ayala-Angulo J; Vu E; Pham Q; Silva J; Dang K; Rezk F; Steward O; Cahalan MD; Lane TE; Walsh CM
Neurobiol Dis; 2020 Jul; 140():104868. PubMed ID: 32276110
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M
Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734
[TBL] [Abstract][Full Text] [Related]
17. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
18. Signalling pathways that inhibit the capacity of precursor cells for myelin repair.
Sabo JK; Cate HS
Int J Mol Sci; 2013 Jan; 14(1):1031-49. PubMed ID: 23296277
[TBL] [Abstract][Full Text] [Related]
19. Multiple Sclerosis: Basic and Clinical.
Buzzard K; Chan WH; Kilpatrick T; Murray S
Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Payne NL; Sun G; Herszfeld D; Tat-Goh PA; Verma PJ; Parkington HC; Coleman HA; Tonta MA; Siatskas C; Bernard CC
PLoS One; 2012; 7(4):e35093. PubMed ID: 22514711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
